CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: usnic acid
Accession: CHEBI:38319
browse the term
Definition: A member of the class of dibenzofurans that is dibenzo[b,d]furan-1(9bH)-one substituted by acetyl groups at positions 2 and 6, hydroxy groups at positions 3 and 7 and methyl groups at positions 8 and 9b.
Synonyms: exact_synonym: 2,6-diacetyl-3,7,9-trihydroxy-8,9b-dimethyldibenzo[b,d]furan-1(9bH)-one
related_synonym: Formula=C18H16O7; InChI=1S/C18H16O7/c1-6-14(22)12(8(3)20)16-13(15(6)23)18(4)10(25-16)5-9(21)11(7(2)19)17(18)24/h5,21-23H,1-4H3; InChIKey=WEYVVCKOOFYHRW-UHFFFAOYSA-N; SMILES=CC(=O)C1=C(O)C=C2Oc3c(c(O)c(C)c(O)c3C(C)=O)C2(C)C1=O; Usninsaeure; usnein; usniacin; usninic acid
xref: Beilstein:346490; CAS:125-46-2
xref_mesh: MESH:C073339
xref: PMID:11034349; PMID:18887895; PMID:19034791; PMID:19349177; PMID:20379653; PMID:24770718; Reaxys:96699; Wikipedia:Usnic_acid
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
usnic acid results in decreased phosphorylation of and results in decreased expression of AKT1 protein
CTD
PMID:25078063
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Apaf1
apoptotic peptidase activating factor 1
increases expression
ISO
usnic acid results in increased expression of APAF1 mRNA
CTD
PMID:32508146
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Atf4
activating transcription factor 4
multiple interactions increases expression
ISO
2-aminoethoxydiphenyl borate inhibits the reaction [usnic acid results in increased expression of ATF4 protein]
CTD
PMID:25870318
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atm
ATM serine/threonine kinase
increases phosphorylation multiple interactions increases expression
ISO
usnic acid results in increased phosphorylation of ATM protein Acetylcysteine inhibits the reaction [usnic acid results in increased phosphorylation of ATM protein] usnic acid results in increased expression of ATM mRNA
CTD
PMID:31715134 PMID:32508146
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Babam2
BRISC and BRCA1 A complex member 2
decreases expression
ISO
usnic acid results in decreased expression of BABAM2 mRNA
CTD
PMID:32508146
NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951
G
Bag1
BAG cochaperone 1
decreases expression
ISO
usnic acid results in decreased expression of BAG1 mRNA
CTD
PMID:32508146
NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075
G
Bag3
BAG cochaperone 3
decreases expression
ISO
usnic acid results in decreased expression of BAG3 mRNA
CTD
PMID:32508146
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
G
Bag4
BAG cochaperone 4
decreases expression
ISO
usnic acid results in decreased expression of BAG4 mRNA
CTD
PMID:32508146
NCBI chr16:66,288,678...66,305,893
Ensembl chr16:66,288,678...66,308,663
G
Bak1
BCL2-antagonist/killer 1
increases expression
ISO
usnic acid results in increased expression of BAK1 mRNA
CTD
PMID:32508146
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression increases expression
ISO
usnic acid results in decreased expression of BAX protein usnic acid results in increased expression of BAX mRNA; usnic acid results in increased expression of BAX protein
CTD
PMID:22285236 PMID:31715134 PMID:32508146
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl10
BCL10, immune signaling adaptor
increases expression
ISO
usnic acid results in increased expression of BCL10 mRNA
CTD
PMID:32508146
NCBI chr 2:234,840,880...234,850,520
Ensembl chr 2:234,840,858...234,850,523
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
usnic acid results in decreased expression of BCL2 mRNA; usnic acid results in decreased expression of BCL2 protein
CTD
PMID:22285236 PMID:25078063 PMID:31715134 PMID:32508146
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2a1
BCL2-related protein A1
decreases expression
ISO
usnic acid results in decreased expression of BCL2A1 mRNA
CTD
PMID:32508146
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
G
Bcl2l11
Bcl2-like 11
decreases expression
ISO
usnic acid results in decreased expression of BCL2L11 mRNA
CTD
PMID:32508146
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
G
Bcl2l2
Bcl2-like 2
increases expression
ISO
usnic acid results in increased expression of BCL2L2 mRNA
CTD
PMID:32508146
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
G
Bfar
bifunctional apoptosis regulator
increases expression
ISO
usnic acid results in increased expression of BFAR mRNA
CTD
PMID:32508146
NCBI chr10:1,552,019...1,585,040
Ensembl chr10:1,552,072...1,585,038
G
Bik
BCL2-interacting killer
increases expression
ISO
usnic acid results in increased expression of BIK mRNA
CTD
PMID:32508146
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
G
Birc2
baculoviral IAP repeat-containing 2
decreases expression
ISO
usnic acid results in decreased expression of BIRC2 mRNA
CTD
PMID:32508146
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
decreases expression
ISO
usnic acid results in decreased expression of BIRC3 mRNA
CTD
PMID:32508146
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
usnic acid results in decreased expression of BIRC5 mRNA
CTD
PMID:32508146
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Bok
BCL2 family apoptosis regulator BOK
increases expression
ISO
usnic acid results in increased expression of BOK mRNA
CTD
PMID:32508146
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
G
Casp1
caspase 1
increases expression
ISO
usnic acid results in increased expression of CASP1 mRNA
CTD
PMID:32508146
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp2
caspase 2
increases expression
ISO
usnic acid results in increased expression of CASP2 mRNA
CTD
PMID:32508146
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
G
Casp3
caspase 3
multiple interactions increases activity increases expression
ISO
3-methyladenine promotes the reaction [usnic acid results in increased activity of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [usnic acid results in increased activity of CASP3 protein]; Chloroquine promotes the reaction [usnic acid results in increased activity of CASP3 protein]; pyrazolanthrone promotes the reaction [usnic acid results in increased activity of CASP3 protein] usnic acid results in increased expression of CASP3 mRNA; usnic acid results in increased expression of CASP3 protein
CTD
PMID:22285236 PMID:25078063 PMID:25870318 PMID:32508146
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
increases cleavage increases expression
ISO
usnic acid results in increased cleavage of CASP4 protein usnic acid results in increased expression of CASP4 mRNA
CTD
PMID:25870318 PMID:32508146
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp6
caspase 6
decreases expression
ISO
usnic acid results in decreased expression of CASP6 mRNA
CTD
PMID:32508146
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp7
caspase 7
multiple interactions increases activity decreases expression
ISO
3-methyladenine promotes the reaction [usnic acid results in increased activity of CASP7 protein]; 4-phenylbutyric acid inhibits the reaction [usnic acid results in increased activity of CASP7 protein]; Chloroquine promotes the reaction [usnic acid results in increased activity of CASP7 protein]; pyrazolanthrone promotes the reaction [usnic acid results in increased activity of CASP7 protein] usnic acid results in decreased expression of CASP7 mRNA
CTD
PMID:25078063 PMID:25870318 PMID:32508146
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
decreases expression
ISO
usnic acid results in decreased expression of CASP8 mRNA
CTD
PMID:32508146
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp8ap2
caspase 8 associated protein 2
increases expression
ISO
usnic acid results in increased expression of CASP8AP2 mRNA
CTD
PMID:32508146
NCBI chr 5:47,014,501...47,052,276
Ensembl chr 5:47,014,667...47,052,275
G
Casp9
caspase 9
decreases expression increases expression
ISO
usnic acid results in decreased expression of CASP9 mRNA usnic acid results in increased expression of CASP9 protein
CTD
PMID:32508146
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
EXP
usnic acid inhibits the reaction [Indomethacin results in increased activity of CAT protein]
CTD
PMID:16169175
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl21
C-C motif chemokine ligand 21
multiple interactions increases expression
ISO
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of CCL21 mRNA usnic acid results in increased expression of CCL21 mRNA
CTD
PMID:21953288 PMID:22777745
NCBI chr 5:56,980,557...56,981,661
Ensembl chr 5:56,980,558...56,981,686
G
Ccl4
C-C motif chemokine ligand 4
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of CCL4 mRNA
CTD
PMID:22777745
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccnc
cyclin C
multiple interactions increases expression
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CCNC mRNA usnic acid results in increased expression of CCNC mRNA
CTD
PMID:21953288 PMID:22777745
NCBI chr 5:35,266,828...35,284,943
Ensembl chr 5:35,266,823...35,296,584
G
Ccnd1
cyclin D1
decreases expression
ISO
usnic acid results in decreased expression of CCND1 protein
CTD
PMID:27369375
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd3
cyclin D3
decreases expression
ISO
usnic acid results in decreased expression of CCND3 protein
CTD
PMID:27369375
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
G
Cd40
CD40 molecule
increases expression
ISO
usnic acid results in increased expression of CD40 mRNA
CTD
PMID:32508146
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd70
Cd70 molecule
increases expression
ISO
usnic acid results in increased expression of CD70 mRNA
CTD
PMID:32508146
NCBI chr 9:2,006,563...2,009,715
Ensembl chr 9:2,006,563...2,009,715
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
usnic acid results in decreased expression of CDK2 protein
CTD
PMID:27369375
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
usnic acid results in decreased expression of CDK4 protein
CTD
PMID:27369375
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
usnic acid results in decreased expression of CDK6 protein
CTD
PMID:27369375
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Chek1
checkpoint kinase 1
increases expression
ISO
usnic acid results in increased expression of CHEK1 mRNA; usnic acid results in increased expression of CHEK1 protein modified form
CTD
PMID:27369375 PMID:32508146
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Chek2
checkpoint kinase 2
increases expression multiple interactions
ISO
usnic acid results in increased expression of CHEK2 mRNA; usnic acid results in increased expression of CHEK2 protein; usnic acid results in increased expression of CHEK2 protein modified form Acetylcysteine inhibits the reaction [usnic acid results in increased expression of CHEK2 protein]
CTD
PMID:27369375 PMID:31715134 PMID:32508146
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
G
Cidea
cell death-inducing DFFA-like effector a
increases expression
ISO
usnic acid results in increased expression of CIDEA mRNA
CTD
PMID:32508146
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
G
Cideb
cell death-inducing DFFA-like effector b
increases expression
ISO
usnic acid results in increased expression of CIDEB mRNA
CTD
PMID:32508146
NCBI chr15:29,252,208...29,256,482
Ensembl chr15:29,252,213...29,256,605
G
Cradd
CASP2 and RIPK1 domain containing adaptor with death domain
increases expression
ISO
usnic acid results in increased expression of CRADD mRNA
CTD
PMID:32508146
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
G
Cryab
crystallin, alpha B
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CRYAB mRNA
CTD
PMID:22777745
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Csf2
colony stimulating factor 2
multiple interactions decreases expression
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CSF2 mRNA usnic acid results in decreased expression of CSF2 mRNA
CTD
PMID:21953288 PMID:22777745
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Cxcl10
C-X-C motif chemokine ligand 10
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CXCL10 mRNA
CTD
PMID:22777745
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases expression
ISO
usnic acid results in decreased expression of CYP1A1 mRNA
CTD
PMID:21953288
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions decreases expression
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CYP2E1 mRNA usnic acid results in decreased expression of CYP2E1 mRNA
CTD
PMID:21953288 PMID:22777745
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 mRNA
CTD
PMID:22777745
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Dapk2
death-associated protein kinase 2
increases expression
ISO
usnic acid results in increased expression of DAPK2 mRNA
CTD
PMID:32508146
NCBI chr 8:66,706,536...66,825,567
Ensembl chr 8:66,706,609...66,825,567
G
Ddb1
damage-specific DNA binding protein 1
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of DDB1 mRNA
CTD
PMID:22777745
NCBI chr 1:207,252,890...207,278,685
Ensembl chr 1:207,252,890...207,278,676
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
2-aminoethoxydiphenyl borate inhibits the reaction [usnic acid results in increased expression of DDIT3 protein] usnic acid results in increased expression of DDIT3 mRNA; usnic acid results in increased expression of DDIT3 protein
CTD
PMID:25870318
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dffa
DNA fragmentation factor subunit alpha
increases expression
ISO
usnic acid results in increased expression of DFFA mRNA
CTD
PMID:32508146
NCBI chr 5:159,540,715...159,553,639
Ensembl chr 5:159,540,715...159,553,633
G
Dffb
DNA fragmentation factor subunit beta
increases expression
ISO
usnic acid results in increased expression of DFFB mRNA
CTD
PMID:32508146
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
decreases phosphorylation
ISO
usnic acid results in decreased phosphorylation of EIF4EBP1 protein
CTD
PMID:25078063
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of ERCC1 mRNA
CTD
PMID:22777745
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Fadd
Fas associated via death domain
increases expression
ISO
usnic acid results in increased expression of FADD mRNA
CTD
PMID:32508146
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
G
Faslg
Fas ligand
multiple interactions increases expression decreases expression
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of FASLG mRNA usnic acid results in increased expression of FASLG mRNA usnic acid results in decreased expression of FASLG mRNA
CTD
PMID:22777745 PMID:32508146
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of FMO1 mRNA
CTD
PMID:22777745
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
usnic acid results in increased expression of GADD45A mRNA
CTD
PMID:32508146
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions increases expression
ISO
NFE2L2 protein promotes the reaction [usnic acid results in increased expression of GCLC protein] usnic acid results in increased expression of GCLC mRNA; usnic acid results in increased expression of GCLC protein
CTD
PMID:27369375
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gpx1
glutathione peroxidase 1
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of GPX1 mRNA
CTD
PMID:22777745
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gsr
glutathione-disulfide reductase
multiple interactions increases expression
ISO
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of GSR mRNA usnic acid results in increased expression of GSR protein
CTD
PMID:22777745 PMID:27369375
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta1
glutathione S-transferase alpha 1
increases expression
ISO
usnic acid results in increased expression of GSTA1 protein
CTD
PMID:27369375
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
H2ax
H2A.X variant histone
increases expression multiple interactions
ISO
usnic acid results in increased expression of H2AX protein; usnic acid results in increased expression of H2AX protein modified form Acetylcysteine inhibits the reaction [usnic acid results in increased expression of H2AX protein]; NFE2L2 protein inhibits the reaction [usnic acid results in increased expression of H2AX protein modified form]
CTD
PMID:27369375 PMID:31715134
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Hrk
harakiri, BCL2 interacting protein
increases expression
ISO
usnic acid results in increased expression of HRK mRNA
CTD
PMID:32508146
NCBI chr12:38,387,484...38,409,652
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of HSP90AB1 mRNA
CTD
PMID:22777745
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of HSPA1A mRNA
CTD
PMID:22777745
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa2
heat shock protein family A (Hsp70) member 2
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of HSPA2 mRNA
CTD
PMID:22777745
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of HSPA5 mRNA
CTD
PMID:22777745
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hsph1
heat shock protein family H (Hsp110) member 1
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of HSPH1 mRNA
CTD
PMID:22777745
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Il18
interleukin 18
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of IL18 mRNA
CTD
PMID:22777745
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of IL1A mRNA
CTD
PMID:22777745
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of IL1B mRNA
CTD
PMID:22777745
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of IL6 mRNA
CTD
PMID:22777745
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Lta
lymphotoxin alpha
multiple interactions increases expression
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of LTA mRNA usnic acid results in increased expression of LTA mRNA
CTD
PMID:22777745 PMID:32508146
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Ltbr
lymphotoxin beta receptor
increases expression
ISO
usnic acid results in increased expression of LTBR mRNA
CTD
PMID:32508146
NCBI chr 4:158,108,884...158,115,339
Ensembl chr 4:158,108,886...158,121,539
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
ISO
usnic acid results in increased phosphorylation of MAPK1 protein
CTD
PMID:25078063
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
ISO
usnic acid results in increased phosphorylation of MAPK3 protein
CTD
PMID:25078063
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
multiple interactions decreases expression increases expression
ISO
3-methyladenine promotes the reaction [usnic acid results in decreased expression of MCL1 protein]; Chloroquine promotes the reaction [usnic acid results in decreased expression of MCL1 protein]; pyrazolanthrone promotes the reaction [usnic acid results in decreased expression of MCL1 protein] usnic acid results in increased expression of MCL1 mRNA
CTD
PMID:25078063 PMID:32508146
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mpo
myeloperoxidase
multiple interactions
EXP
usnic acid inhibits the reaction [Indomethacin results in increased activity of MPO protein]
CTD
PMID:16169175
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
ISO
usnic acid results in decreased phosphorylation of and results in decreased expression of MTOR protein
CTD
PMID:25078063
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Naip6
NLR family, apoptosis inhibitory protein 6
decreases expression
ISO
usnic acid results in decreased expression of NAIP mRNA
CTD
PMID:32508146
NCBI chr 2:31,507,423...31,559,098
Ensembl chr 2:31,507,424...31,570,542
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
NFE2L2 protein inhibits the reaction [usnic acid results in increased expression of H2AX protein modified form]; NFE2L2 protein promotes the reaction [usnic acid results in increased expression of GCLC protein]; usnic acid results in increased expression of and affects the localization of NFE2L2 protein
CTD
PMID:27369375
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nod1
nucleotide-binding oligomerization domain containing 1
increases expression
ISO
usnic acid results in increased expression of NOD1 mRNA
CTD
PMID:32508146
NCBI chr 4:84,060,871...84,111,668
Ensembl chr 4:84,060,880...84,111,404
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO EXP
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of NOS2 mRNA usnic acid inhibits the reaction [Indomethacin results in increased activity of NOS2 protein]
CTD
PMID:16169175 PMID:22777745
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
usnic acid results in increased expression of NQO1 protein
CTD
PMID:27369375
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Orai1
ORAI calcium release-activated calcium modulator 1
increases expression multiple interactions
ISO EXP
usnic acid results in increased expression of ORAI1 protein 2-aminoethoxydiphenyl borate inhibits the reaction [usnic acid results in increased expression of ORAI1 protein]
CTD
PMID:25870318
NCBI chr12:33,533,151...33,548,361
Ensembl chr12:33,534,344...33,548,405
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
usnic acid results in increased cleavage of PARP1 protein
CTD
PMID:31715134
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pdk1
pyruvate dehydrogenase kinase 1
decreases phosphorylation
ISO
usnic acid results in decreased phosphorylation of PDK1 protein
CTD
PMID:25078063
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
G
Por
cytochrome p450 oxidoreductase
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of POR mRNA
CTD
PMID:22777745
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
increases expression multiple interactions
ISO
usnic acid results in increased expression of PRKDC protein Acetylcysteine inhibits the reaction [usnic acid results in increased expression of PRKDC protein]
CTD
PMID:31715134
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
G
Ptgs1
prostaglandin-endoperoxide synthase 1
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of PTGS1 mRNA
CTD
PMID:22777745
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Rad50
RAD50 double strand break repair protein
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of RAD50 mRNA
CTD
PMID:22777745
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
G
Ripk2
receptor-interacting serine-threonine kinase 2
increases expression
ISO
usnic acid results in increased expression of RIPK2 mRNA
CTD
PMID:32508146
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
G
Rpa3
replication protein A3
increases expression
ISO
usnic acid results in increased expression of RPA3 mRNA
CTD
PMID:32508146
NCBI chr 4:36,304,649...36,307,755
Ensembl chr 4:36,304,651...36,307,709
G
Rps6kb1
ribosomal protein S6 kinase B1
decreases phosphorylation
ISO
usnic acid results in decreased phosphorylation of RPS6KB1 protein
CTD
PMID:25078063
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Serpine1
serpin family E member 1
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of SERPINE1 mRNA
CTD
PMID:22777745
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sqstm1
sequestosome 1
increases degradation
ISO
usnic acid results in increased degradation of SQSTM1 protein
CTD
PMID:25078063
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Stim1
stromal interaction molecule 1
increases expression
ISO EXP
usnic acid results in increased expression of STIM1 protein
CTD
PMID:25870318
NCBI chr 1:156,656,246...156,818,777
Ensembl chr 1:156,656,013...156,818,363
G
Tank
TRAF family member-associated NFKB activator
increases expression
ISO
usnic acid results in increased expression of TANK mRNA
CTD
PMID:32508146
NCBI chr 3:46,114,230...46,190,270
Ensembl chr 3:46,114,274...46,190,264
G
Tnf
tumor necrosis factor
multiple interactions decreases expression
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of TNF mRNA usnic acid results in decreased expression of TNF mRNA
CTD
PMID:22777745 PMID:32508146
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf10b
TNF receptor superfamily member 10b
increases expression
ISO
usnic acid results in increased expression of TNFRSF10A mRNA
CTD
PMID:32508146
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tnfrsf11b
TNF receptor superfamily member 11B
increases expression
ISO
usnic acid results in increased expression of TNFRSF11B mRNA
CTD
PMID:32508146
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
ISO
usnic acid results in increased expression of TNFRSF1A mRNA
CTD
PMID:32508146
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf21
TNF receptor superfamily member 21
increases expression
ISO
usnic acid results in increased expression of TNFRSF21 mRNA
CTD
PMID:32508146
NCBI chr 9:17,879,156...17,954,085
Ensembl chr 9:17,879,156...17,954,085
G
Tnfrsf22
tumor necrosis factor receptor superfamily, member 22
increases expression
ISO
usnic acid results in increased expression of TNFRSF10C mRNA
CTD
PMID:32508146
NCBI chr 1:198,840,452...198,860,713
Ensembl chr 1:198,840,453...198,856,309
G
Tnfrsf8
TNF receptor superfamily member 8
increases expression
ISO
usnic acid results in increased expression of TNFRSF8 mRNA
CTD
PMID:32508146
NCBI chr 5:157,123,183...157,168,421
Ensembl chr 5:157,123,185...157,168,421
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
ISO
usnic acid results in increased expression of TNFRSF9 mRNA
CTD
PMID:32508146
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf10
TNF superfamily member 10
increases expression
ISO
usnic acid results in increased expression of TNFSF10 mRNA
CTD
PMID:32508146
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnfsf13
TNF superfamily member 13
increases expression
ISO
usnic acid results in increased expression of TNFSF13 mRNA
CTD
PMID:32508146
NCBI chr10:54,400,054...54,403,723
Ensembl chr10:54,400,065...54,403,042
G
Tnfsf15
TNF superfamily member 15
increases expression
ISO
usnic acid results in increased expression of TNFSF15 mRNA
CTD
PMID:32508146
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
G
Tnfsf4
TNF superfamily member 4
increases expression
ISO
usnic acid results in increased expression of TNFSF4 mRNA
CTD
PMID:32508146
NCBI chr13:73,723,329...73,746,809
Ensembl chr13:73,723,329...73,746,788
G
Tnfsf8
TNF superfamily member 8
increases expression
ISO
usnic acid results in increased expression of TNFSF8 mRNA
CTD
PMID:32508146
NCBI chr 5:77,250,942...77,277,364
Ensembl chr 5:77,251,373...77,277,421
G
Tp53
tumor protein p53
decreases expression increases expression multiple interactions
ISO
usnic acid results in decreased expression of TP53 protein usnic acid results in increased expression of TP53 mRNA; usnic acid results in increased expression of TP53 protein Acetylcysteine inhibits the reaction [usnic acid results in increased expression of TP53 protein]
CTD
PMID:22285236 PMID:31715134 PMID:32508146
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp63
tumor protein p63
increases expression
ISO
usnic acid results in increased expression of TP63 mRNA
CTD
PMID:32508146
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Traf3
Tnf receptor-associated factor 3
increases expression
ISO
usnic acid results in increased expression of TRAF3 mRNA
CTD
PMID:32508146
NCBI chr 6:130,199,696...130,307,168
Ensembl chr 6:130,206,484...130,305,481
G
Traf5
TNF receptor-associated factor 5
increases expression
ISO
usnic acid results in increased expression of TRAF5 mRNA
CTD
PMID:32508146
NCBI chr13:103,569,944...103,618,747
Ensembl chr13:103,572,314...103,618,709
G
Traf6
TNF receptor associated factor 6
increases expression
ISO
usnic acid results in increased expression of TRAF6 mRNA
CTD
PMID:32508146
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
G
Ugt1a5
UDP glucuronosyltransferase family 1 member A5
multiple interactions increases expression
ISO
[usnic acid co-treated with Lipopolysaccharides] results in increased expression of UGT1A4 mRNA usnic acid results in increased expression of UGT1A4 mRNA
CTD
PMID:21953288 PMID:22777745
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Xbp1
X-box binding protein 1
increases splicing
ISO
usnic acid results in increased splicing of XBP1 mRNA
CTD
PMID:25870318
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Xrcc1
X-ray repair cross complementing 1
multiple interactions
ISO
[usnic acid co-treated with Lipopolysaccharides] results in decreased expression of XRCC1 mRNA
CTD
PMID:22777745
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all